Search research articles
Contact Us
Filters
Showing results (11-20 of 40) with videos related to
Page
of 4
Sort By:
JAMA
|
July 13, 1994
Ethics, economics, and the publication policies of major medical journals
K Schulman, D P Sulmasy, D Roney
Pharmacoeconomics
|
February 7, 1996
A strategy for collecting pharmacoeconomic data during phase II/III clinical trials
J Mauskopf, K Schulman, L Bell, et al.
Breast Cancer Research and Treatment
|
January 1, 1996
Evaluation of quality of life for diverse patient populations
K R Yabroff, B P Linas, K Schulman
Seminars in Perinatology
|
October 1, 1978
Role of nutrition in the management of the pregnant diabetic patient
P K Schulman, M T Gyves, I R Merkatz
Wiley Interdisciplinary Reviews. Developmental Biology
|
March 3, 2015
Specification of the somatic musculature in Drosophila
Krista C Dobi, Victoria K Schulman, Mary K Baylies
Development (Cambridge, England)
|
December 17, 2013
Translocating myonuclei have distinct leading and lagging edges that require kinesin and dynein
Eric S Folker, Victoria K Schulman, Mary K Baylies
Fly
|
July 13, 2013
A method for reversible drug delivery to internal tissues of Drosophila embryos
Victoria K Schulman, Eric S Folker, Mary K Baylies
Development (Cambridge, England)
|
September 7, 2012
Muscle length and myonuclear position are independently regulated by distinct Dynein pathways
Eric S Folker, Victoria K Schulman, Mary K Baylies
Health Economics
|
May 1, 1997
Confidence intervals for cost-effectiveness ratios: a comparison of four methods
D Polsky, H A Glick, R Willke, et al.
Diabetes Care
|
May 1, 1980
Results of individualized intervention in gestational diabetes
M T Gyves, P K Schulman, I R Merkatz
Page
of 4
Search research articles
Search
Showing results (11-20 of 40) with videos related to
Sort By:
Page
of 4
JAMA
|
July 13, 1994
Ethics, economics, and the publication policies of major medical journals
K Schulman, D P Sulmasy, D Roney
Pharmacoeconomics
|
February 7, 1996
A strategy for collecting pharmacoeconomic data during phase II/III clinical trials
J Mauskopf, K Schulman, L Bell, et al.
Breast Cancer Research and Treatment
|
January 1, 1996
Evaluation of quality of life for diverse patient populations
K R Yabroff, B P Linas, K Schulman
Seminars in Perinatology
|
October 1, 1978
Role of nutrition in the management of the pregnant diabetic patient
P K Schulman, M T Gyves, I R Merkatz
Wiley Interdisciplinary Reviews. Developmental Biology
|
March 3, 2015
Specification of the somatic musculature in Drosophila
Krista C Dobi, Victoria K Schulman, Mary K Baylies
Development (Cambridge, England)
|
December 17, 2013
Translocating myonuclei have distinct leading and lagging edges that require kinesin and dynein
Eric S Folker, Victoria K Schulman, Mary K Baylies
Fly
|
July 13, 2013
A method for reversible drug delivery to internal tissues of Drosophila embryos
Victoria K Schulman, Eric S Folker, Mary K Baylies
Development (Cambridge, England)
|
September 7, 2012
Muscle length and myonuclear position are independently regulated by distinct Dynein pathways
Eric S Folker, Victoria K Schulman, Mary K Baylies
Health Economics
|
May 1, 1997
Confidence intervals for cost-effectiveness ratios: a comparison of four methods
D Polsky, H A Glick, R Willke, et al.
Diabetes Care
|
May 1, 1980
Results of individualized intervention in gestational diabetes
M T Gyves, P K Schulman, I R Merkatz
Page
of 4